HLB Life Science Co., Ltd. (067630.KQ)
KRW 9780.0
(-1.81%)
KRW 9780.0
(-1.81%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 23.78 Billion KRW | 43.24% |
| 2022 | 15.38 Billion KRW | 27.79% |
| 2021 | 12.03 Billion KRW | 27.52% |
| 2020 | 9.43 Billion KRW | -17.83% |
| 2019 | 11.48 Billion KRW | -5.77% |
| 2018 | 12.19 Billion KRW | 161.47% |
| 2017 | 4.66 Billion KRW | 8.96% |
| 2016 | 4.27 Billion KRW | -22.59% |
| 2015 | 5.52 Billion KRW | 63.42% |
| 2014 | 3.38 Billion KRW | 2.36% |
| 2013 | 3.3 Billion KRW | -55.81% |
| 2012 | 7.47 Billion KRW | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 5.25 Billion KRW | -2.79% |
| 2024 Q1 | 5.4 Billion KRW | -19.62% |
| 2023 Q2 | 5 Billion KRW | 8.93% |
| 2023 Q4 | 6.72 Billion KRW | 39.05% |
| 2023 Q3 | 4.83 Billion KRW | -3.37% |
| 2023 FY | 22.03 Billion KRW | 43.24% |
| 2023 Q1 | 4.59 Billion KRW | 4.33% |
| 2022 Q2 | 3.06 Billion KRW | -6.43% |
| 2022 Q4 | 4.4 Billion KRW | -5.54% |
| 2022 Q3 | 4.66 Billion KRW | 52.16% |
| 2022 FY | 15.38 Billion KRW | 27.79% |
| 2022 Q1 | 3.27 Billion KRW | -1.63% |
| 2021 Q2 | 3.57 Billion KRW | 39.38% |
| 2021 Q4 | 3.32 Billion KRW | 28.59% |
| 2021 Q1 | 2.56 Billion KRW | -94.33% |
| 2021 Q3 | 2.58 Billion KRW | -27.71% |
| 2021 FY | 12.03 Billion KRW | 27.52% |
| 2020 Q2 | 1.3 Billion KRW | -94.88% |
| 2020 FY | 9.43 Billion KRW | -17.83% |
| 2020 Q4 | 45.26 Billion KRW | 300.97% |
| 2020 Q3 | 11.28 Billion KRW | 762.06% |
| 2020 Q1 | 25.59 Billion KRW | 79.79% |
| 2019 Q3 | 10.61 Billion KRW | 112.08% |
| 2019 Q2 | 5 Billion KRW | -40.81% |
| 2019 Q1 | 8.45 Billion KRW | -37.82% |
| 2019 FY | 11.48 Billion KRW | -5.77% |
| 2019 Q4 | 14.23 Billion KRW | 34.12% |
| 2018 Q4 | 13.6 Billion KRW | 1052.68% |
| 2018 Q3 | 1.17 Billion KRW | -35.68% |
| 2018 Q2 | 1.83 Billion KRW | -18.04% |
| 2018 Q1 | 2.23 Billion KRW | -65.2% |
| 2018 FY | 12.19 Billion KRW | 161.47% |
| 2017 Q1 | 1.07 Billion KRW | -35.64% |
| 2017 Q3 | 1.28 Billion KRW | -11.67% |
| 2017 Q4 | 6.43 Billion KRW | 401.04% |
| 2017 Q2 | 1.45 Billion KRW | 35.66% |
| 2017 FY | 4.66 Billion KRW | 8.96% |
| 2016 Q3 | 1.32 Billion KRW | 80.74% |
| 2016 Q4 | 1.66 Billion KRW | 25.71% |
| 2016 FY | 4.27 Billion KRW | -22.59% |
| 2016 Q2 | 732.7 Million KRW | 75.37% |
| 2016 Q1 | 417.79 Million KRW | -92.77% |
| 2015 Q1 | 707.28 Million KRW | -41.66% |
| 2015 Q2 | 4.06 Billion KRW | 474.8% |
| 2015 Q4 | 5.77 Billion KRW | 300.05% |
| 2015 Q3 | 1.44 Billion KRW | -64.47% |
| 2015 FY | 5.52 Billion KRW | 63.42% |
| 2014 Q1 | 504.05 Million KRW | -48.57% |
| 2014 Q2 | 698.49 Million KRW | 38.57% |
| 2014 FY | 3.38 Billion KRW | 2.36% |
| 2014 Q3 | 967.6 Million KRW | 38.53% |
| 2014 Q4 | 1.21 Billion KRW | 25.29% |
| 2013 Q2 | 329.91 Million KRW | -29.05% |
| 2013 Q3 | 1.52 Billion KRW | 363.67% |
| 2013 Q4 | 980.09 Million KRW | -35.93% |
| 2013 FY | 3.3 Billion KRW | -55.81% |
| 2013 Q1 | 464.96 Million KRW | -91.38% |
| 2012 Q3 | 109.27 Million KRW | 0.0% |
| 2012 FY | 7.47 Billion KRW | 0.0% |
| 2012 Q4 | 5.39 Billion KRW | 4834.35% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|